NeuroVax

· Immune Response BioPharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NeuroVax, covering 2020-03-11 to 2020-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis [Phase 2, Phase 3]